Reckitt Benckiser Group (LON:RB) PT Lowered to GBX 6,500
Reckitt Benckiser Group (LON:RB) had its target price dropped by JPMorgan Chase & Co. from GBX 7,700 ($101.29) to GBX 6,500 ($85.50) in a research report issued on Tuesday, Borsen Zeitung reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 5.30% from the company’s current price.
RB has been the subject of several other reports. Citigroup reissued a “buy” rating on shares of Reckitt Benckiser Group in a report on Wednesday, March 11th. Barclays cut their price target on shares of Reckitt Benckiser Group from GBX 6,700 ($88.13) to GBX 6,400 ($84.19) and set a “buy” rating for the company in a report on Tuesday. Deutsche Bank reissued a “buy” rating and issued a GBX 7,200 ($94.71) price target on shares of Reckitt Benckiser Group in a report on Thursday, February 27th. Royal Bank of Canada reissued an “underperform” rating on shares of Reckitt Benckiser Group in a report on Friday, March 6th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 7,150 ($94.05) price target on shares of Reckitt Benckiser Group in a report on Friday, February 28th. Three analysts have rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of GBX 6,355 ($83.60).
RB traded up GBX 223 ($2.93) on Tuesday, hitting GBX 6,173 ($81.20). The company’s stock had a trading volume of 4,044,904 shares, compared to its average volume of 1,720,000. The company’s 50 day simple moving average is GBX 6,093.46 and its 200-day simple moving average is GBX 6,103.72. The firm has a market cap of $44.22 billion and a P/E ratio of -11.88. Reckitt Benckiser Group has a 12 month low of GBX 5,510 ($72.48) and a 12 month high of GBX 8,191.30 ($107.75). The company has a quick ratio of 0.41, a current ratio of 0.56 and a debt-to-equity ratio of 130.80.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: Overbought
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.